Floatz logo

INTERLEUKIN-11

Von Willebrand Disease

University of Pittsburghprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Von Willebrand Disease cohort.

Asset / SponsorPhaseRating
Alphanate Sd/Ht
Grifols Biologicals, LLC
Phase 4BB
FACTOR VIII (HUMAN)
Bio Products Laboratory
Phase 3BB
Oprelvekin
University of Pittsburgh
Phase 2CCC
Von Willebrand Factor
National Center for Research Resources (NCRR)
Phase 1CC
Tranexamic Acid
Assiut University
D
HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX
Assiut University
D
Rondaptivon pegol sodium
Medical University of Vienna
Phase 2NR
Cyclokapron
Mary M. Gooley Hemophilia Center
N/ANR

Same molecule, other indications

INTERLEUKIN-11 is also rated in:

hemophilia ADormant
CCC
Indicative ·
54 / 100
View asset →
thrombocytopeniaDormant
CCC
Indicative ·
53 / 100
View asset →
colorectal carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →